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Appearance of Lipid-Laden
Intima and Neovascularization
After Implantation of Bare-Metal Stents
Extended Late-Phase Observation
by Intracoronary Optical Coherence Tomography
Masamichi Takano, MD,* Masanori Yamamoto, MD,† Shigenobu Inami, MD,*
Daisuke Murakami, MD,† Takayoshi Ohba, MD,† Yoshihiko Seino, MD,† Kyoichi Mizuno, MD*
Tokyo and Chiba, Japan
Objectives We examined the neointimal characteristics of bare-metal stents (BMS) in extended late phase by the use of
optical coherence tomography (OCT).
Background The long-term neointimal features after BMS implantation have not yet been fully characterized.
Methods Intracoronary OCT observation of BMS segments was performed during the early phase (6 months, n  20)
and late phase (5 years, n  21) after implantation. Internal tissue of the BMS was categorized into normal
neointima, characterized by a signal-rich band without signal attenuation, or lipid-leaden intima, with marked
signal attenuation and a diffuse border. In addition, the presence of disrupted intima and thrombus was evalu-
ated. Neovascularization was defined as small vesicular or tubular structures, and the location of the microves-
sels was classified into peristent or intraintima.
Results Normal neointima proliferated homogeneously, and lipid-laden intima was not observed in the early phase. In
the late phase, lipid-laden intima, intimal disruption, and thrombus frequently were found in comparison with
the early phase (67% vs. 0%, 38% vs. 0%, and 52% vs. 5%, respectively; p  0.05). Peristent neovascularization
demonstrated a similar incidence between the 2 phases. The appearance of intraintima neovascularization was
more prevalent in the late phase than the early phase (62% vs. 0%, respectively; p  0.01) and in segments
with lipid-laden intima than in nonlipidic segments (79% vs. 29%, respectively; p  0.026).
Conclusions This OCT study suggests that neointima within the BMS often transforms into lipid-laden tissue during an ex-
tended period of time and that expansion of neovascularization from peristent to intraintima contributes to ath-
erosclerotic progression of neointima. (J Am Coll Cardiol 2010;55:26–32) © 2010 by the American College of
Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.08.032t
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aare-metal stents (BMS) implantation is a standard therapy
n percutaneous coronary intervention. Histopathologically,
eointima are mainly composed of vascular smooth muscle
ells proliferating over stent struts associated with vascular
ealing response in the early phase (1). Although the authors
f several clinical follow-up studies (2,3) have shown the
ong-term efficacy and safety of BMS, progressive lumen
arrowing presenting with angiographic in-stent restenosis
ISR) is significantly associated with late adverse events such as
hrombosis and myocardial infarction from 5 to 10 years after
rom the *Division of Cardiology, Nippon Medical School, Tokyo, Japan; and the
Cardiovascular Center, Chiba-Hokusoh Hospital, Nippon Medical School, Chiba,
apan.p
Manuscript received May 27, 2009; revised manuscript received August 28, 2009,
ccepted August 31, 2009.he struts are deployed (2,3). Therefore, a hypothesis has arisen
hat neointimal tissue inside the BMS changes during a 5-year
eriod. Intracoronary optical coherence tomography (OCT)
ith high-resolution images (10 m) provides visualization
f microstructures on vessel walls and accurate tissue charac-
erization in living patients (4–6). This OCT examination
ocusing on features inside the BMS was performed to validate
eointimal changes during an extended period (5 years) after
heir implantation.
See page 33
ethods
atient selection. Angiographic and OCT examinations
fter successful BMS implantation were performed in 20
atients6 months (early-phase group) and 21 patients5
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December 29, 2009/January 5, 2010:26–32 OCT Observation for BMS in Extended Late Phaseears (late-phase group). Patients of the late-phase group
eceived plural examinations, one at 6 months (angiogra-
hy alone as first follow-up) and one at 5 years (angiog-
aphy and OCT as last follow-up). The reason for the last
ollow-up was: 1) evidence of myocardial ischemia such as
ilent myocardial ischemia, stable angina, or acute coronary
yndrome (ACS) (7); or 2) planned follow-up angiography for
ther stent segments. Partial data of the early-phase group
ere reported previously (8), and patients who had undergone
arget lesion revascularization (TLR) due to ISR were excluded
o estimate the natural process of the initial BMS. All patients
rovided their informed consent for the procedure, which was
pproved by the institutional review board.
ngiographic analysis. Coronary angiograms were ana-
yzed by quantitative coronary angiography with a
omputer-assisted, automated edge detection algorithm
CMS, MEDIS, Nuenen, the Netherlands). The reference
essel diameter, minimum lumen diameter, and diameter
tenosis (DS) were measured. We defined ISR as 50% of
S. Any angiographic abnormal findings (filling defect,
aziness, or lumen irregularity) were qualitatively evaluated.
CT imaging and analysis. The OCT procedure and
natomical exclusion criteria have been previously reported
8). The tissue inside the BMS was categorized as follows:
) normal neointima, a signal-rich band without signal
Figure 1 Normal Intima and Atherosclerotic Intima
Struts of a bare-metal stent (BMS) are clearly identified as high-signal spots
with shadows (white arrowheads). (A) Homogeneous high-signal band within
the BMS shows proliferating normal neointima. (B) Cholesterol crystals (red
arrow) are recognized as linear, marked high-signal structures within the BMS.
(C) A well-delineated, signal-poor mass with sharp border shows a calcified
nodule (red arrows). (D) Lipid-laden intima is observed as a signal-poor area
with diffuse border (*). The stent struts in this area are invisible. This cross
section shows thin-cap fibroatheroma-like intima (the thinnest fibrous cap 
30 m; arrow, angle of lipidic tissue  184.5°).ttenuation (9); 2) cholesterol
rystals (i.e., oriented, linear,
ighly reflecting structures) (10);
) calcification (i.e., well-
elineated, signal-poor mass
ith sharp border) (4); and
) lipid-leaden intima (i.e., dif-
use border, signal-poor region
ue to marked signal attenua-
ion) (4) (Fig. 1). Thrombus was
efined as a mass protruding into
he lumen (dimension 250
m) (5), and disrupted intima
ere evaluated. Neovasculariza-
ion differentiated from any side
ranches was defined as small vesicular or tubular structures
diameter 300 m), and the location of the microvessels
as divided into peristent (attaching to stent struts or
xterior the center between the struts and lumen) or
ntraintima (interior the center between the struts and
umen) (Fig. 2). The minimum lumen area and maximum
ngle of lipid distribution were measured. When fibrous cap
hickness at the thinnest part was 65 m and angle of
ipidic tissue was 180° (6), the intima was defined as a
hin-cap fibroatheroma (TCFA)-like intima.
Figure 2 Thrombus, Intimal Disruption, and Neovascularization
White arrowheads indicate stent struts. (A) A massive thrombus protruding
into the lumen (red arrow) and lipid-laden intima (*) are found in a patient
with unstable angina. (B) Disrupted intima (red arrow) and lipidic tissue (*)
are seen. (C) A cluster of small vesicular structures around stent struts,
peristent neovascularization (red arrows) is observed in a patient of the early
phase group. Normal neointima circumferentially covers the struts. (D) Intrain-
tima neovascularization (red arrows) is seen as tubular and vesicular struc-
tures nearby the lumen. Neovascular beds are located at the margins of the
lipidic area (*). A microvessel at the 9-o’clock region is expanding from the
peristent into the intima.
Abbreviations
and Acronyms
ACS  acute coronary
syndrome
BMS  bare-metal stent(s)
DS  diameter stenosis
ISR  in-stent restenosis
OCT  optical coherence
tomography
TCFA  thin-cap
fibroatheroma
TLR  target lesion
revascularization
S
C
w
C
t
s
R
P
c
w
(
A
e
s
q
b
l
e
i
A
T
g
p
a
a
f
T
c
I
O
t
w
c
t
5
i
8
p
w
a
e
i
2
c
g
n
t
n
or bloc
28 Takano et al. JACC Vol. 55, No. 1, 2010
OCT Observation for BMS in Extended Late Phase December 29, 2009/January 5, 2010:26–32tatistical analysis. Data are presented as mean  SD.
ategorical variables are presented as frequencies, and they
ere analyzed by the Fisher exact test or chi-square test.
ontinuous data were tested by paired or unpaired Student
test. A p value 0.05 was considered to be statistically
ignificant.
esults
atient characteristics. Baseline characteristics, including
oronary risk factors and the reason for BMS implantation,
ere similar between the early- and late-phase groups
Table 1).
ngiographic findings and clinical presentations. The
arly- and late-phase groups consisted of 22 stents in 20
egments and 24 stents in 21 segments, respectively. The
uantitative coronary angiography parameters did not differ
etween the early-phase group and the first follow-up of the
ate-phase group. In the late-phase group, myocardial isch-
mia was documented in 2 patients with silent myocardial
schemia, 7 patients with stable angina, and 4 patients with
CS (3 unstable angina and 1 acute myocardial infarction).
he minimum lumen diameter was smaller and DS was
reater at the last follow-up in comparison with the early-
hase group and the first follow-up, and angiographic
Patient CharacteristicsTable 1 Patient Characteristics
Ea
Age, yrs
Sex, male
Coronary risk factors
Diabetes mellitus
Dyslipidemia
Hypertension
Current smoking
Obesity
Family history of coronary artery disease
Ejection fraction, %
Hemodialysis
Multivessel disease
Previous coronary artery bypass surgery
Reason for stenting
Acute coronary syndrome
Silent myocardial ischemia or stable angina
Medication
Aspirin
Thienopyridines
Dual antiplatelet therapy
ACE inhibitor or ARB
Beta-blockers
Calcium-channel blockers
Statins
Insulin
Oral hypoglycemic agents
Values are mean  SD or n (%).
ACE  angiotensin-converting enzyme; ARB  angiotensin II receptbnormalities were observed in 3 ACS patients (1 haziness and 2 wall irregularities). New ISR occurred at the last
ollow-up in 13 patients, and they received clinical-driven
LR (Table 2). There were no differences in procedural and
linical characteristics between patients with and without
SR.
CT findings. In the early-phase group, normal neoin-
ima was observed in all cross sections of the patients. There
as 1 thrombus in 1 case (5%). In the late-phase group,
alcification, cholesterol crystals, lipid-laden intima, disrup-
ion, and thrombus accounted for 10%, 14%, 67%, 38%, and
2% of patients, respectively. The angle of lipid-laden
ntima and thickness of fibrous cap was 213  84° (range
6° to 360°) and 80  59 m (range 30 to 250 m) in 14
atients who had lipid-laden intima, and TCFA-like intima
as observed in 6 patients (29%). The frequencies of
bnormal findings were greater in the late phase than in the
arly phase (Fig. 3). The minimum lumen area was smaller
n the late phase in comparison with the early phase (3.4 
.4 mm2 vs. 5.2  1.9 mm2; p  0.011). Overall, neovas-
ularization was found at the ratio of 60% in the early-phase
roup and of 86% in the late-phase group (p  0.06), and
eovascularization of the early-phase group was localized in
he peristent area. Although the incidence of peristent
eovascularization was similar between the 2 groups (60%
ase Group
20)
Late-Phase Group
(n  21) p Value
 11 62 11 0.55
(80) 21 (100) 0.10
(35) 8 (38) 0.84
(75) 14 (67) 0.56
(70) 12 (57) 0.39
(25) 7 (33) 0.56
(40) 6 (29) 0.44
(15) 3 (14) 0.95
 12 59 10 0.80
0 2 (10) 0.26
(25) 8 (38) 0.37
0 2 (10) 0.26
(60) 16 (76) 0.27
(40) 5 (24)
(100) 18 (86) 0.08
(90) 11 (52) 0.007
(90) 9 (43) 0.001
(60) 11 (52) 0.62
(35) 6 (29) 0.66
(15) 2 (10) 0.59
(75) 13 (62) 0.37
0 1 (5) 0.32
(20) 4 (19) 0.94
kers.rly-Ph
(n 
65
16
7
15
14
5
8
3
60
5
12
8
20
18
18
12
7
3
15
4nd 81%, respectively; p  0.14), intraintima neovascular-
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December 29, 2009/January 5, 2010:26–32 OCT Observation for BMS in Extended Late Phasezation was more prevalent in the late phase than in the early
hase (62% vs. 0%) (Fig. 4). The change in DS between the
rst and last follow-ups was greater, and ratios of ISR and
LR were greater in patients (or segments) with lipid-laden
Figure 3 Frequencies of Atherosclerotic Findings
In the late phase, several kinds of atherosclerotic changes are found. The fre-
quencies of lipid-laden intima, disruption, and thrombus are significantly
greater in the late phase than in the early phase. §p  0.001; ¶p  0.01.
TCFA  thin-cap fibroatheroma.
ngiographic Findings and Clinical PresentationTable 2 Angiographic Findings and Clinical Presentation
Early-Phase Group
(n  20)
Location of stent segment
Right coronary artery 9 (45)
Left anterior descending artery 8 (40)
Left circumflex artery 3 (15)
Stent size, mm 3.3 0.4 (n  22)
Stent length, mm 18.1 6.4 (n  22)
Number of stents 1.1 0.3
Two overlapping stents 2 (10)
CAG and OCT
Duration from stenting, months 4.6 1.8
Clinical presentation
Stent follow-up 20 (100)
Silent myocardial ischemia or stable angina 0
Acute coronary syndrome 0
Quantitative coronary angiography
Reference vessel diameter, mm 2.94 0.41
Length of stent segment, mm 18.8 7.0
Minimum lumen diameter, mm 2.20 0.27
Diameter stenosis, % 25.2 10.8
In-stent restenosis 0
Qualitative abnormality 0
Target lesion revascularization 0
alues are n (%) or mean SD. *Early-phase group versus last follow-up of the late-phase group; †
f late-phase group.
CAG  coronary angiography; OCT  optical coherence tomography.ntima in comparison with those without lipid-laden intima
Table 3). Lipid-laden intima was more frequent in
ymptomatic than in asymptomatic patients (p  0.001).
Figure 4 Prevalence of Neovascularization
The prevalence of overall and peristent neovascularization does not differ between
the early and late phase. In contrast, the incidence of intraintima neovasculariza-
tion is greater in the late phase than in the early phase. †p  0.001.
Late-Phase Group
(n  21) p Value*
9 (43)
7 (33) 0.76
5 (24)
3.4 0.5 (n  24) 0.46
17.7 5.7 (n  24) 0.82
1.1 0.4 0.72
3 (14) 0.68
t Follow-Up CAG Only Last Follow-Up CAG and OCT
5.6 2.1 91.5 25.9† 0.001
21 (100) 8 (38)† 0.001
0 9 (43)† 0.001
0 4 (19) 0.06
3.03 0.48 2.98 0.53 0.79
19.4 6.8 0.78
2.17 0.32 1.64 0.67† 0.001
28.4 12.1 44.9 21.9† 0.001
0 13 (62)† 0.001
0 3 (14) 0.08
0 13 (62)† 0.001
5 between the first and last follow-ups. p NS between early-phase group and the first follow-upFirs
p  0.0
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OCT Observation for BMS in Extended Late Phase December 29, 2009/January 5, 2010:26–32he frequencies of disruption, thrombus, and intraintima
eovascularization were greater in segments with lipid-
aden intima than in those without lipid-laden intima (Fig.
). There was no relationship between intraintima neovas-
ularization and thrombus formation (p  0.39). In the late
hase, 4 patients with ACS had both intimal disruption and
hrombus and they showed angiographic ISR (Fig. 6).
iscussion
his extended late-phase (5 years) OCT observation after
MS implantation demonstrated that: 1) neointima often
ransforms into lipid-laden tissue with lumen narrowing;
) neovascularization expanding from the peristent area into
he intima may be responsible for atherosclerotic change;
nd 3) advanced atherosclerotic progression such as intimal
isruption and thrombus formation may be associated with
ecurrence of myocardial ischemia, including ACS.
Proliferating tissue within the BMS segment in the early
hase was recognized as homogeneous OCT signals. In
ontrast, various signal patterns of the late phase indicated
rowth of several sorts of tissues during an extended period
f time. Notably, 67% of the patients had lipid-laden
ntima, and TCFA-like appearance accounted for 29%. The
se of OCT enables one to detect lipidic elements of arterial
all with a high sensitivity and specificity (90%) (4).
ipid-laden intima was correlated with intimal disruption
nd thrombus formation, and the rather complex morphol-
gy resembled a vulnerable plaque, typically observed at the
ulprit lesion of ACS (5). A post-mortem pathological
Observations in the Group With Late Optical CoTable 3 Observations in the Group With Lat
With Li
Age, yrs
Coronary risk factors
Diabetes mellitus
Dyslipidemia
Hypertension
Current smoking
Reason for stenting
Acute coronary syndrome
Silent myocardial ischemia or stable angina
Medication
ACE inhibitor or ARB
Statins
Oral hypoglycemic agents
Clinical presentation
Silent myocardial ischemia or stable angina
Acute coronary syndrome
Angiographic findings
Change in diameter stenosis, % 3
In-stent restenosis
Qualitative abnormality
Target lesion revascularization
Values are mean  SD or n (%).
Abbreviatons as in Table 1.tudy demonstrated that prominent infiltration by lipid-aden macrophages into neointima and adherent thrombus
re found on disrupted lumen 4 years after BMS place-
ent (11). Moreover, specimens obtained by directional
Figure 5 Comparison Between Lipidic and
Nonlipidic Stent Segments at Late Phase
Stent segments with lipid-laden intima frequently have intimal disruption,
thrombus, and intraintima neovascularization in comparison to the segments
without lipid-laden intima. Peristent neovascularization is commonly found in
both groups. #p  0.05.
ce Tomographyical Coherence Tomography
den Intima
14)
Without Lipid-Laden Intima
(n  7) p Value
13 65 5 0.54
3) 2 (29) 0.53
1) 4 (57) 0.51
7) 4 (57) 0.99
3) 1 (14) 0.19
9) 5 (71) 0.72
1) 2 (29)
3) 5 (71) 0.22
7) 5 (71) 0.53
1) 1 (14) 0.69
7) 1 (14) 0.06
9) 0 0.12
16.3 5.9 10.0 0.001
6) 1 (14) 0.001
1) 0 0.19
6) 1 (14) 0.001herene Opt
pid-La
(n 
61
6 (4
10 (7
8 (5
6 (4
11 (7
3 (2
6 (4
8 (5
3 (2
8 (5
4 (2
0.8
12 (8
3 (2
12 (8
c
c
(
t
p
O
r
e
m
a
u
r
p
s
n
o
i
a
m
e
c
e
o
b
c
c
a
B
a
v
t
w
t
n
p
i
s
d
r
w
31JACC Vol. 55, No. 1, 2010 Takano et al.
December 29, 2009/January 5, 2010:26–32 OCT Observation for BMS in Extended Late Phaseoronary atherectomy from new ISR lesions 5 years are
omposed of thrombus and atherosclerotic materials
cholesterol clefts, necrotizing foam cells, and inflamma-
ory cells) facing on healed neointimal layer (12). These
athological findings are consistent with the current
CT findings.
A serial angiographic evaluation of the BMS segments
evealed a triphasic luminal response characterized by an
arly narrowing phase during the course of 6 months, a
edium-term regression phase from 6 months to 3 years,
nd a late narrowing phase beyond 4 years (2). It is
nderstood that early lumen narrowing and medium-term
egression are attributed to neointimal thickening by cell
roliferation and thinning by neointimal remodeling, re-
pectively (13). The present study showed that lumen
arrowing during the late phase, including new appearance
f ISR, remarkably increased in segments with lipid-laden
ntima than in nonlipidic segments. Therefore, activated
therosclerotic processes may promote subsequent neointi-
al remodeling and late lumen narrowing.
In atheroma of nonstent segments, neovascular networks
Figure 6 Angiographic and Optical Coherence Tomographic Fin
(A) Coronary angiograms of a patient with unstable angina show new in-stent rest
implantation 131.8 months ago. (B) Optical coherence tomography shows the pre
(white arrowhead) within the stent. (C) Another cross section shows intraintima (
nary stent had been implanted in the left anterior descending artery 68.5 months
the stent and peristent microvessel (red arrow) are observed.xpand from adventitia into plaque, and intraplaque mi- drovessels bring recruitment of circulating macrophages and
rythrocytes through the vasa vasorum. After phagocytosis
f erythrocytes containing free cholesterol in their mem-
ranes by infiltrated macrophages, the deposition of foam
ells and activated macrophages invite enlargement of ne-
rotic core and plaque destabilization (14). Neovascular beds
ppear in peristent neointimal tissue at early phase after
MS implantation (15). Peristent microvessels probably
dvance toward the interior and build up intraintima neo-
ascularization with time. The current results indicated that
he expression of lipid-laden intima is closely associated
ith intimal disruption, thrombus formation, and intrain-
ima neovascularization. Therefore, expanded intraintima
eovascularization may play a key role in atherosclerotic
rogression and surrounding tissue instability, as well as
ntraplaque neovascularization of nonstent segments.
In the current series, ACS increased in 4 patients who
howed angiographic ISR and OCT findings of intimal
isruption and thrombus. A large-scale angiographic study
evealed that ISR in the late phase is significantly associated
ith adverse cardiac events such as thrombosis and myocar-
in the Late Phase
and haziness in the left anterior descending artery. This patient received stent
of lipid-laden intima (*), intimal disruption (red arrow), and small thrombus
ow) and peristent (white arrowheads) neovascular beds. (D) In this case, coro-
usly. Angiograms show no in-stent restenosis. (E and F) Normal neointima withindings
enosis
sence
red arr
previoial infarction (3). According to Hasegawa et al. (12), 43%
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OCT Observation for BMS in Extended Late Phase December 29, 2009/January 5, 2010:26–32f new ISR lesions that develop beyond 5 years are clinically
epresented as ACS. Our results propose the concept that
hrombus formation originating from atherosclerotic inti-
al disruption of BMS segment can arise in the extended
ate phase, and the phenomenon may be one potential cause
f very late thrombosis.
tudy limitations. The study population was relatively
mall, and some selection bias might have influenced the
esults. Target BMS segments were not serially observed by
he use of OCT because this imaging device has only
ecently been developed. Larger and serial studies are
ecessary for understanding the differences in intimal de-
eneration associated with clinical presentation. Although
ith the use of OCT there is the possibility of identifying
eovascularization (6,16), the diagnostic accuracy is indis-
inct. Signal attenuation due to superficial thrombus (or
ipid-laden intima) and limited penetration depth of OCT
mages (2 mm) interrupted the acquisition of information
n the stent (or neointimal) area, vascular remodeling, and
eovascularization in deep layers. Finally, intraintima hem-
rrhage could not be diagnosed because of the absence of
CT criteria.
onclusions
his OCT study suggests that neointima within the BMS
ften transforms into atherosclerotic tissue in the extended
ate phase and that atherosclerotic progression of neointima
ay be attributed to neovascular expansion from peristent to
ntraintima.
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